Q301--Molecular Residual Disease (MRD) Testing Services

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
36C10G22R0020
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
621511 Medical Laboratories

Notice details come from SAM.gov. Updated .

Notice text

2 versions

Update #2 · Latest ·

36C10G22R0020

AMENDMENT 0001

The purpose of this amendment is to;

1. Provide answers to the questions submitted. The questions and the Governments response are provided on the attachment MRDT Questions Compiled as of Amendment 0001.

No further questions will be accepted on this solicitation. This amendment does not extend the proposal due date. The closing date for proposal submission remains July 5, 2022, 10:00 AM EDT.

Update #1 ·

The VA s National Oncology Program supports Molecular Residual Disease Testing (MRDT) testing for Veterans with cancer or at risk for cancer across ~130 VA Medical Centers. The National Oncology Program (NOP) has identified MRDT as a candidate for VHA-wide (otherwise referred to as national ) standardization and intends to secure specialized, comprehensive reference laboratory services and support from contractor(s) with the capability and expertise to provide molecular testing.

Files

Show all 13

Notice history

Notice Type Posted
Q301--Molecular Residual Disease (MRD) Testing Services Award Award Notice
This notice Latest solicitation Solicitation
Q301--Molecular Residual Disease (MRD) Testing Services Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity